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The HPV infection in men (HIM) study examines the natural history of genital HPV infection in men.
Genotyping methods used in this study identify 37 α-HPV types; however, the viral type could not be
identiﬁed in approximately 22% of male genital specimens that were HPV PCR positive. Our aim was to
genotype HPV-unclassiﬁed specimens by sequencing PGMY09/11, GP5+/6+ or FAP59/64 PCR products.
Using this approach we were able to detect 86 unique HPV types among 508 of 931 specimens analyzed.
We report for the ﬁrst time the presence of a broad range of α-, β- and γ-HPV at the male genitals.
& 2013 Elsevier Inc. All rights reserved.Introduction
Human papillomaviruses (HPV) are primarily transmitted by
sexual contact and infection by these viruses is strongly associated
with the development of cancers of the cervix, vagina, and vulva in
women, cancer of the penis in men, in addition to cancers of the
anus and oropharynx in both genders (IARC, 2007). To date more
than 150 different HPV types have been described. Forty α-HPV
types have been shown to infect the anogenital tract of which
13 are classiﬁed as high-risk or oncogenic according to the World
Health Organization (IARC, 2007).
HPV taxonomy relies on L1 late gene sequence variability: new
viral types are deﬁned when the L1 sequence differs by at least 10%
from the closest known type. The majority of HPV types groups in
three different genera: α-papillomavirus, predominantly isolated
from mucosal and genital lesions, and β- and γ-papillomavirusll rights reserved.
ional em Oncologia – ICESPAv.
sar - São Paulo, 01246-000,mostly detected in cutaneous specimens (Bernard et al., 2010).
Most studies of genital HPV infection in men have examined only
α-HPV types; the distribution of other HPV types present at the
male genitals remains unknown. In the HIM study (Giuliano et al.,
2008), over 66% of men tested positive for HPV at their ﬁrst study
visit; however, the viral type could not be identiﬁed in nearly 22%
of these men (e.g., HPV PCR positive, no genotype speciﬁed)
(Akogbe et al., 2012). Understanding the natural history of HPV
infection in men is essential to better understand the transmission
of these viruses and to study HPV related disease. In the present
study, we aimed to sequence HPV-unclassiﬁed genital specimens
using three different generic HPV primer sets to identify α-, β- and
γ-HPV infections in a well-deﬁned cohort of adult men.Results
A total of 931 specimens from the external genitalia of 649 men
were included in this study: 348 specimens from 244 men in the
USA, 338 specimens from 233 men in Brazil, and 245 specimens
from 172 men in Mexico. These genital specimens were collected
from a range of visits, through the end of 2008, which corresponds
L. Sichero et al. / Virology 443 (2013) 214–217 215to the HIM study baseline through 3 years of follow up: 118, 279,
210, 147, 114, 52, 8, and 3 samples from visits 1, 2, 3, 4, 5, 6, 7, and 8,
respectively.
Among all 931 specimens, 393 were characterized by sequen-
cing PGMY09/11 PCR products. Next, nested PCR with GP5+/6+
primers was able to amplify 34 samples; and ﬁnally the FAP59/64
ampliﬁed 398 additional samples. Overall, 106 (11.4%) were HPV
negative using any of the three primers sets (13.5%, 9% and 12% of
the specimens from the USA, Brazil and Mexico, respectively),
indicating that a fraction of unclassiﬁed HPV detection most likely
represents spurious PCR products. Among the PCR-positive speci-
mens using either primers PGMY09/11 or FAP59/64, HPV could not
be genotyped in 133 (14.3%) of specimens since BlastN analysis
indicated high similarity to partial HPV sequences in GeneBank as
yet without type designation. Additionally, in 182 specimens
(19.6%) direct sequencing of the FAP59/64 amplicons was unsuc-
cessful due to overlapping peak patterns most possibly due to the
presence of more than one HPV type.
We were able to successfully type 508 (54.6%) previously
unclassiﬁed specimens, comprising 86 different HPV types: 13.7%
α-HPV, 38.7% β-HPV, and 2% γ-HPV. Alpha-HPVs were detected in
9.5% (33/348), 21.3% (72/338) and 9.4% (23/245) of the specimens
from the USA, Brazil and Mexico, respectively. Some divergence
was observed concerning HPV type frequency across populations;
for instance, HPV-6 was more commonly detected among Brazilian
samples (13/338; 3.8%), whereas HPV-2 was detected in eight of
348 samples from the USA (2.3%) (Fig. 1). Most samples analyzed
contained β-HPV: 44.8% (n¼156), 32.5% (n¼110) and 38.7%
(n¼95) of the specimens from the USA, Brazil and Mexico,
respectively. HPV β-2 species was the most frequent and diverse
group: we detected 18 different HPV genotypes from this speciesFig. 1. HPV type frequency by country of α-, β-, and γ-HPVs in unclassiﬁed samples of the
indicated in the x-axis.of which the more common were HPV-107 and HPV-120. HPV-22
was more frequent among samples from Mexico (12/245; 4.9%).
In a small proportion of the samples, we identiﬁed HPV types of
three different γ-HPV species; only HPV-133 was detected in all
three populations. HPV-147 which has not been taxonomically
classiﬁed thus far (http://pave.niaid.nih.gov/#home) was detected
in one sample from each country.
Among the 649 men included in this study, we analyzed two or
more specimens from 199 individuals. DNA of the same HPV type
was detected in only 57 men, in more than one visit (Table 1).
HPV-107 and HPV-120 were the most common types detected at
more than one study visit.Discussion
Using a PCR-sequencing procedure, we were able to show that
over 11% of unclassiﬁed HPV infections (i.e., PCR-positive but
genotyping-negative) were truly HPV negative and that 55% of
such infections were positive for a broad distribution of α-, β- and
γ-HPV types. These unclassiﬁed HPV infections could result from
non-speciﬁc ampliﬁcation of genes unrelated to HPV or represent
viral types different from the 37 α-HPVs possibly genotyped by the
Linear Array HPV genotyping test.
We detected α-HPVs in 128 samples, 80 of which contained
HPV types that should have been identiﬁed with the linear array
genotyping test. These false-negative results are likely due to low
viral copy numbers which were detected on a different PCR
reaction followed by sequencing, a more sensitive technical
approach. Interestingly, by sequencing PGMY09/11 and GP5+/6+
PCR products we were able to identify a wide range of β-HPV typesHIM study. The y-axis indicates frequency of individual HPV types. HPV species are
Table 1
Number of HPV persistent detection by country in unclassiﬁed samples of the
HIM study.
Genus Specie Type HPV EUA Brazil Mexico Total
α-HPV α6 HPV-56 1 1
α4 HPV-2 1 1
α10 HPV-6 1 1
HPV-44 1 1
β-HPV β1 HPV-5 1 1 2
HPV-14D 1 1
HPV-20 1 1
HPV-24 1 1
HPV-47 1 1
HPV-105 1 1
HPV-118 1 1 1 3
β1 HPV-22 3 3
HPV-23 1 1
HPV-37 2 2
HPV-38b 1 1 2 4
HPV-80 1 1 2
HPV-107 3 6 2 11
HPV-110 1 1 2
HPV-120 5 6 1 12
Uncharacterized 1 4 1 6
Total 20 23 14 57
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designed to detect α-HPVs. However, a high proportion of β-HPV
specimens were further characterized and identiﬁed by sequence
analysis of FAP59/64 PCR products. Additionally, all γ-HPV speci-
mens were discovered using FAP59/64 primers (data not shown).
Overall, we detected 37 different HPV types from four β-HPV
species. Some differences were observed regarding the prevalence
of individual types among the three geographical locations.
We observed in 14% of the samples high sequence identity with
HPVs not fully characterized, most of which consisted of partial
FAP HPV sequences previously detected in the skin of healthy
individuals, dialysis patients and renal transplant recipients
(Antonsson et al., 2000). The detection of 133 putative new HPV
types in human skin samples supports that β- and γ-HPVs are
more diverse than α-HPV (Forslund, 2007). Furthermore,
sequences with overlapping peak patterns indicate the presence
of more than one HPV type, as was observed in 19.5% of the
samples analyzed in this study. This could be overcome by
sequencing multiple clones or by using the Luminex technology
(Gheit et al., 2007). In fact, the latter system was employed in the
analysis of 17 unclassiﬁed HPV penile samples from the HIM study
and showed that most specimens contained more than three HPV
cutaneous types (T. Gheit and M. Tommasino, personal commu-
nication). These results suggest that an even greater amount of
genital samples from the HIM study may actually contain DNA
from cutaneous HPV types. These include α-HPV positive samples
that were both characterized using the Linear Array genotyping
test and PCR-sequencing. Multiple infection by β-HPVs are com-
monly detected in cutaneous tumors and normal skin samples
while using FAP59/64 primers set (Ekström et al., 2011; Forslund
et al., 1999).
Former surveys of penile HPV prevalence mainly focused on
high-risk genital α-HPV infections (IARC, 2007). Our data points to
a broader distribution of β- and γ-HPVs than was previously
recognized, as these viral types were primarily described in skin
samples and for this reason we may not exclude the possibility
that a high number of cutaneous HPV also circulate in the
anogenital area of women. Recently, HPV types from both genera
were also detected in condyloma samples (Johansson et al., in
press). Further, a wide spectrum of known and novel HPV types
that phylogenetically cluster into the β- and γ-HPV genera wereidentiﬁed in the oral cavity (Bottalico et al., 2011). Nevertheless, it
seems that only α-HPVs infections are associated to oral cancer
development (Paolini et al., 2013). In addition to certain types of
sexual behavior that may increase the risk of β-HPV infection in
the anogenital region, direct hand to penis contact may favor viral
transmission. Further, the presence of cutaneous HPV DNA in the
penis could reﬂect deposition of virions released from other body
sites with productive infections.
Persistence of high-risk α-HPV types constitutes the most
important factor for the development of cervical cancer (IARC,
2007). In this study, DNA of the same β-HPV type was detected in
more than one visit in 47 of 250 (18.8%) of individuals with at least
one specimen harboring viral types from this branch. Data in the
literature concerning persistence of β-HPV is limited. Still, it was
described that 43% of skin infections by cutaneous HPVs persisted
for 6 years in healthy individuals and renal transplant recipients
(Hazard et al., 2007). Interestingly, a lack of association between
HPV persistence and presence of warts was observed.
We report for the ﬁrst time the presence of a broad range of
novel and candidate β- and γ-HPV at the male genitals. The
implication of β-HPV persistence for the pathogenesis of cancer
is unknown as yet and requires further investigation.Materials and methods
Study population
The HPV infection in men (HIM) study is a multinational,
prospective study of HPV natural history in men recruited from
three different populations (São Paulo, Brazil; Cuernavaca, Mexico;
Tampa, Florida). Over 4000 men ages 18–70 years were enrolled in
the study and were followed every 6 months for up to 4 years.
Details of the HIM study are described elsewhere (Giuliano et al.,
2008, 2011). This analysis is restricted to 931 samples from 649
men who had at least one unclassiﬁed genital HPV specimen
collected between March 2005 and December 2008. No exclusions
were made for men with external genital lesions. This study was
approved by the ethics committees of the hospitals and institu-
tions involved. All participants gave written informed consent.
Genital specimen collection and HPV detection
At each study visit, genital specimens were obtained from the
coronal sulcus, glans penis, penile shaft, and scrotum using Dacron
(Digene, Gaithersburg, MD, USA) swabs, and combined into one
sample. HPV DNA was extracted using the QIAGen Media Kit
(QIAGen, Valencia, CA, USA) and PCR (PGMY09/11) was performed.
Specimens were genotyped using the linear array method (Roche
Molecular Diagnostics, Alameda, CA, USA) which identiﬁes 37
α-HPVs commonly detected in the cervix (Gravitt et al., 1998).
Specimens that tested PCR-positive and genotyping-negative were
considered unclassiﬁed infections, and underwent additional
typing.
Typing of unclassiﬁed samples
Puriﬁed DNA was genotyped by direct sequencing of the PCR
amplimers generated by PGMY09/11 primers or cloning of the
amplicons followed by sequencing. Next, 1 ml of PGMY09/11
negative products was used in a nested PCR using GP5+/6+
primers (de Roda Husman et al., 1995) and positive samples were
cloned and sequenced. Finally, nested PGMY09/11-GP5+/6+ PCR
negative samples were submitted to a new PCR using FAP59/64
primers and amplimers were analyzed by direct sequencing
(Forslund et al., 1999). All PCRs were performed using AmpliTaq
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sequencing, PCR products were puriﬁed using EXO SAP-IT (GE
Healthcare, Buckinghamshire, UK). Sequencing reactions were
performed in an ABI 3130XL Genetic Analyzer (AB Applied Bio-
systems, CA, USA) using the BigDyes Terminator v3.1 Cycle
Sequencing kit (AB Applied Biosystems, CA, USA). Sequence
identity was determined by comparison with the BlastN database:
sequences with scores higher than 90% within at least 200 bp were
conclusively typed.Role of the funding source
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